pseudoephedrine hydrochloride
NDC 45802-107, Pseudoephedrine HCl, tablet, film coated, extended release, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-107
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA075153
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-107 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-107-52 | 45802010752 | 10 BLISTER PACK in 1 CARTON (45802-107-52) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 45802010752
GET /v1/drugs/nadac/45802010752
Use it
Look up 45802-107 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-107 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-107. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.